Toggle menu

4AT

Start date:
August 2015
End date:
Predicted June 2017
Co-ordinated by:
EMERGE team on behalf of University of Edinburgh and NHS Lothian
Main trial site:
RIE

The 4AT as a triage test for delirium: a validation study in acutely hospitalised older patients.

Aim

To determine the diagnostic accuracy of the 4AT for delirium versus the reference standard of a DSM-IV diagnosis

Trial Design

Patients undergo a standard delirium assessment, and either the 4AT or the Confusion Assessment Method (CAM). Clinical outcomes and resource utilisation are recorded at 12 weeks after admission.

Eligibility criteria

Patients aged over 70 admitted to the Emergency Department.

Chief Investigator

Professor Alasdair MacLullich

Professor of Geriatric Medicine

Research Team

Allan MacRaild

Stroke Lead Research Nurse

Jill Steven

Senior Research Nurse - 4AT study

Mia Paderanga

Senior Research Nurse

Megan McGrath

Senior Research Nurse

Emma Ward

Research Administrator

Related news

4AT team attends British Geriatric Society conference

4AT team attends British Geriatric Society conference

5 Nov 2015 | Allan MacRaild

Emerge sent two research nurses to the British Geriatric Society (BGS) conference. Jill Steven and Allan MacRaild are recruiting to a study entitled The 4AT as a triage test for delirium: a validation study in acutely hospitalised older patients. This study is a first collaboration between Emerge and Medicine of the Elderly with this study being led by Professor Alasdair MacLullich.

Read more
A study to assess a tool to diagnose Delirium

More EMERGE Trials

Intervention
1. Ambulatory Device, Rocket Pleural vent insertion
2. Standard Treatment, Aspiration +/- chest drain
Primary Outcome Measures
To assess whether use of an ambulatory device (Rocket Pleural Vent) and treatment strategy reduces hospital stay. Total length of stay in hospital up to 30 days post randomisation. Up to 30 days post randomisation.

Read more

RAMPP trial

RAMPP trial - Randomised Controlled Trial: Pleural vent (rocket) V standard care in Primary Spontaneous Pnuemothorax

Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)

Read more

ATTEST2

Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)

Identification and characterization of the clinical toxicology of novel psychoactive substances (NPS) by laboratory analysis of biological samples from recreational drug users.

Read more

IONA

Identification of Novel Psychoactive Substances (IONA)